The drugs industry is an enormous multibillion businesses encompassing an immense number of companies involved in the design, production and marketing of drugs worldwide. According to the type of drugs the market can be dived into the following segments: diabetes, antifungal, antidepressant, antithrombotic, hepatitis drugs, analgesics and a far more.
Currently, the drugs market is undergoing a recovery phase in the wake of the recent decline provoked by the economic slump. The market growth is spurred by increasing demand for drugs across the globe, rising incidence of chronic as well as infectious diseases, population ageing, product innovations and constant technological advancements. North America and Europe are the most prominent regional markets. Bristol-Myers Squibb, Pharmacia, GlaxoSmithKline, Merck & Co, Novartis, Eli Lilly, Pfizer, Johnson & Johnson, Allergan, Schering-Plough, Bayer and Abbott Labs are amid global drugs arena giants.
A huge collection of the research reports covering the drugs market at different geographies can be found under this MarketPublishers’ catalogue. The researches provide comprehensive assessment of the market, characterize major market trends and disclose essential market indicators. The reports describe the competitive scenario and indicate top market players. In addition, future prospects for the drugs market are thoroughly studied in the research reports.
Publications found:
8,499
Sort by:
Neuroblastoma (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Neuroblastoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Neuroblastoma - Drugs In Development, 2021, provides a...
October 2021
1265 pages
Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021
US$ 2,500.00
Non-Hodgkin Lymphoma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Drugs In Development, 20...
October 2021
4641 pages
Obesity (Metabolic Disorder) - Drugs in Development, 2021
US$ 2,500.00
Obesity (Metabolic Disorder) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Obesity - Drugs In Development, 2021, provides an...
October 2021
763 pages
Pontine Glioma (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Pontine Glioma (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pontine Glioma - Drugs In Development, 2021, provides...
October 2021
649 pages
Vaginal Cancer (Oncology) - Drugs in Development, 2021
US$ 2,000.00
Vaginal Cancer (Oncology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vaginal Cancer - Drugs In Development, 2021, provides...
October 2021
579 pages
Antibody Drugs: Technologies and Global Markets
US$ 2,750.00
... growth rate (CAGR) of 6.3% from 2017 through 2022. The global antibody drugs market for autoimmune diseases reached $37.3 billion in 2016. The market ... $37.5 billion in 2017, at a CAGR of 5.1% from 2017 through 2022. The global antibody drugs market for lymphoma reached $37.3 billion in 2016. The market should ...
October 2021
133 pages
Analgesics in Belarus
US$ 990.00
... generics, which also limited retail value growth. Euromonitor International's Analgesics in Belarus report offers a comprehensive guide to the size and shape ... the market is set to change. Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic. Data coverage: market sizes (historic and forecasts), ...
October 2021
23 pages
Cough, Cold and Allergy (Hay Fever) Remedies in Belarus
US$ 990.00
... children and adults. Decongestant rubs registe... Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Belarus report offers a comprehensive guide to the size and ...
October 2021
22 pages
Digestive Remedies in Belarus
US$ 990.00
... of these products and their... Euromonitor International's Digestive Remedies in Belarus report offers a comprehensive guide to the size and ... coverage: Diarrhoeal Remedies, IBS Treatments, Indigestion and Heartburn Remedies, Laxatives, Motion Sickness Remedies, Paediatric Digestive Remedies. Data coverage: ...
October 2021
22 pages
Omega 3 Supplements Market Size, Share & Trends Analysis Report By Source (Fish, Krill Oil), By Form (Soft Gels, Capsules), By End User (Adults, Infants), By Functionality, By Distribution Channel, And Segment Forecasts, 2020 - 2028
US$ 5,950.00
... according to a new report by Grand View Research, Inc. Omega 3 supplements market is anticipated to witness a significant growth on account of high ... provide a positive outlook to the omega 3 supplements market. Increasing opportunities from the sports nutrition market due to rising preference for leading ...
October 2021
150 pages
Vitamin China E-News 202109
US$ 3,186.00
... , a leading producer of sodium dichromate and VK3 in China. It is likely to start equipment overhauls and ... the raw material and product to some extent. VA prices rebounded in early period of this month as a result ... into vitamin APIs, with the VB5 and VB6 projects being advanced further. Vitamins China E-News is ...
October 2021
45 pages
Antiviral Drugs Market Size, Share & Trends Analysis Report By Drug Class, By Application (HIV, Hepatitis, Herpes, Influenza), By Type (Branded, Generics), By Region, And Segment Forecasts, 2021 - 2028
US$ 5,950.00
The global antiviral drugs market is expected to reach a value of USD 69.2 billion by 2025, based on a new report by ... ). Introduction of efficient antiviral drugs with benefits such as rapid action, increased sensitivity, and lower adverse effects is expected to serve this market as a high-impact ...
October 2021
120 pages
Global Anti-Fungal Drugs Market, By Drug Class (Azoles, Echinocandins, Polyenes, Allylamines, Others), By Indication (Candidiasis, Aspergillosis, Mucormycosis, Dermatophytosis, Others), By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection), By Route of Administration (Topical, Oral, Parenteral, Others), By End User (Homecare, Hospitals, Clinics, Others) By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy), By Region, Competition Forecast & Opportunities, 2026
US$ 4,900.00
Global anti-fungal drugs market is expected to reach USD28484.69 million by 2026, growing at CAGR of 10.39% over the forecast period. Fungal infections can lead to diseases including fungal pneumonia,...
October 2021
114 pages
Anti CD47 Drugs Market by Target Disease Indication (Acute Myeloid Leukemias, Non-Hodgkin Lymphoma, Colorectal Cancers, Diffuse Large B-cell Lymphoma, Myelodysplastic Syndromes, Non-Small Cell Lung Cancers, Ovarian Epithelial Cancer, Oral Muscositis, Small Cell Lung Cancers), Type of Molecule (Biologics and Small Molecule) Key Players and Key Geographical Regions (US, France, Germany, Italy, Spain, UK, Australia, China, India and Israel): Industry Trends and Global Forecasts, 2021-2035
US$ 4,799.00
The anti CD47 market is expected to reach USD 0.1 billion in 2023 and anticipated to grow at a CAGR of 42.9% during the forecast period 2021-2035. According to the World Health Organization (WHO), can...
October 2021
178 pages
Cough, Cold and Allergy (Hay Fever) Remedies in Russia
US$ 990.00
... growth of cough, cold and allergy (hay fever) remedies in 2018, as consumers focused on more affordable and necessary products. Euromonitor International's Cough, Cold and Allergy (Hay Fever) Remedies in Russia report ...
September 2021
26 pages
Digestive Remedies in Russia
US$ 990.00
... the increasing pressure on infrastructure and sewerage networks. Euromonitor International's Digestive Remedies in Russia report offers a comprehensive guide to the size and shape of the ...
September 2021
25 pages
NRT Smoking Cessation Aids in Russia
US$ 990.00
... of OTC nicotine-free smoking cessation aids in Russia may have a negative impact on the development of NRT smoking cessation aids over the forecast period. ... its brand, Sopharma AO may attrac... Euromonitor International's NRT Smoking Cessation Aids in Russia report offers a comprehensive guide to the size and ...
September 2021
23 pages
NRT Smoking Cessation Aids in Vietnam
US$ 990.00
... such as sweets and gums when quitting smoking. Many of them were not aware of NRT smoking cessation aids. Euromonitor International's NRT Smoking Cessation Aids in Vietnam report offers a comprehensive guide to the ... data. Why buy this report? Get a detailed picture of the NRT Smoking Cessation Aids market; Pinpoint growth sectors and identify factors driving change ...
September 2021
17 pages
20s Proteasome - Drugs in Development, 2021
US$ 3,500.00
20s Proteasome - Drugs in Development, 2021 SUMMARY 20s Proteasome pipeline Target constitutes close to 9 molecules. Out of which approximately 6 molecules are developed by companies and remaining by...
September 2021
76 pages
Anaphylaxis (Immunology) - Drugs in Development, 2021
US$ 2,000.00
Anaphylaxis (Immunology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaphylaxis - Drugs In Development, 2021, provides an...
September 2021
67 pages
Aplastic Anemia (Hematology) - Drugs in Development, 2021
US$ 2,000.00
Aplastic Anemia (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia - Drugs In Development, 2021, prov...
September 2021
138 pages
Diphtheria (Infectious Disease) - Drugs in Development, 2021
US$ 2,000.00
Diphtheria (Infectious Disease) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diphtheria - Drugs In Development, 2021, provid...
September 2021
93 pages
Fanconi Anemia (Hematology) - Drugs in Development, 2021
US$ 2,000.00
Fanconi Anemia (Hematology) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fanconi Anemia - Drugs In Development, 2021, provid...
September 2021
93 pages
Gastritis (Gastrointestinal) - Drugs in Development, 2021
US$ 2,000.00
Gastritis (Gastrointestinal) - Drugs in Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastritis - Drugs In Development, 2021, provides a...
September 2021
99 pages
